@article{article, title  = {{Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis}},

 publisher = {{National Society for Cutaneous Medicine}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Silverberg J and Barbarot S and Gooderham M and Simon J and Simpson E and Kurbasic A and Olsen C and Cork M}},

 doi = {{10.25251/skin.5.supp.9}},

 volume = {{5}},

 journal = {{SKIN The Journal of Cutaneous Medicine}},

 issue = {{1}},

 pages = {{s9-s9}},

 note = {{Accessed on 2024/12/22}}}